Finance

Lists
Why is 000739 down 7,69%?
Dive Deeper
000739:SHE
Apeloa Pharmaceutical Co Ltd
21,62 CNY
-7,69%
(-1,80) 1D
19 ოქტ, 15:04:21 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000739...
Open
23,02 CNY
High
23,57 CNY
Low
21,08 CNY
Mkt. cap
27,13 მლრდ.
Avg. vol.
16,57 მლნ.
Volume
35,80 მლნ.
Dividend
1,74%
Quarterly dividend
0,09 CNY
Ex-dividend date
8 ოქტ. 2026
P/E ratio
29,34
52-wk high
28,50 CNY
52-wk low
14,89 CNY
EPS
0,74 CNY
Shares outstanding
1,16 მლრდ.
No. of employees
7 ათ.
Open
23,02 CNY
High
23,57 CNY
Low
21,08 CNY
Mkt. cap
27,13 მლრდ.
Avg. vol.
16,57 მლნ.
Volume
35,80 მლნ.
Dividend
1,74%
Quarterly dividend
0,09 CNY
Ex-dividend date
8 ოქტ. 2026
P/E ratio
29,34
52-wk high
28,50 CNY
52-wk low
14,89 CNY
EPS
0,74 CNY
Shares outstanding
1,16 მლრდ.
No. of employees
7 ათ.
News stories
From web sources and news partners
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas. Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development. Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd
CEO-
Employees6,79 ათ.
Founded1989
Headquarters-
SectorPharmaceutical industry
Websiteapeloa.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
2,32 მლრდ.
2,02 მლრდ.
2,45 მლრდ.
2,38 მლრდ.
Cost of goods sold
1,75 მლრდ.
1,48 მლრდ.
1,73 მლრდ.
1,69 მლრდ.
Cost of revenue
1,75 მლრდ.
1,48 მლრდ.
1,73 მლრდ.
1,69 მლრდ.
Research and development expenses
140,81 მლნ.
146,16 მლნ.
134,93 მლნ.
143,88 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
231,94 მლნ.
275,50 მლნ.
219,12 მლნ.
203,71 მლნ.
Operating expense
330,71 მლნ.
483,17 მლნ.
380,47 მლნ.
371,82 მლნ.
Total operating expenses
2,08 მლრდ.
1,96 მლრდ.
2,11 მლრდ.
2,06 მლრდ.
Operating income
239,75 მლნ.
60,19 მლნ.
336,71 მლნ.
311,76 მლნ.
Other non operating income
-7,84 მლნ.
7,46 მლნ.
-33,21 მლნ.
31,72 მლნ.
EBT including unusual items
180,55 მლნ.
227,06 მლნ.
297,81 მლნ.
323,80 მლნ.
EBT excluding unusual items
242,07 მლნ.
80,73 მლნ.
306,22 მლნ.
288,49 მლნ.
Income tax expense
43,43 მლნ.
36,57 მლნ.
48,54 მლნ.
50,52 მლნ.
Effective tax rate
24,06%
16,10%
16,30%
15,60%
Other operating expenses
-29,24 მლნ.
53,54 მლნ.
13,18 მლნ.
11,46 მლნ.
Net income
137,22 მლნ.
190,41 მლნ.
249,02 მლნ.
273,35 მლნ.
Net profit margin
5,92%
9,43%
10,17%
11,51%
Earnings per share
-
-
-
-
Interest and investment income
22,93 მლნ.
46,65 მლნ.
10,66 მლნ.
17,28 მლნ.
Interest expense
-5,29 მლნ.
-8,06 მლნ.
-7,95 მლნ.
-8,10 მლნ.
Net interest expenses
17,64 მლნ.
38,60 მლნ.
2,71 მლნ.
9,18 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
380,74 მლნ.
225,73 მლნ.
502,26 მლნ.
478,57 მლნ.
Gain or loss from assets sale
1,16 მლნ.
-9,03 მლნ.
-
-136,29 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები